Page 9 - மருந்து ஆம்ப் சாதனம் வளர்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்து ஆம்ப் சாதனம் வளர்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்து ஆம்ப் சாதனம் வளர்ச்சி Today - Breaking & Trending Today

Explainer: Activists, drug groups split over suspending COVID-19 shot patents

A World Trade Organization (WTO) council is discussing a proposal by India and South Africa that COVID-19 vaccine and other medical patents be suspended to speed up technology transfers to manufacturers with spare production capacity. ....

United States , United Kingdom , South Africa , Bruxelles Capitale , Richard Hatchett , Ludwig Burger , Phil Blenkinsop , Tedros Adhanom Ghebreyesus , Josephine Mason , Nick Macfie , John Miller , Stephanie Nebehay , Ngozi Okonjo Iweala , Thomson Reuters Trust Principles , Countries Vaccine Manufacturers Network , World Health Organization , Us Chamber , Coalition For Epidemic Preparedness Innovations , A World Trade Organization , Oxford University Sarah Gilbert , World Trade Organization , Trade Related Aspects , Intellectual Property , Doctors Without Borders , Tedros Adhanom , Pharmaceutical Research ,

Kidney problems in COVID-19 patients unrelated to remdesivir: EU drugs regulator

Europe's drugs regulator said on Friday its safety panel found no evidence that Gilead's remdesivir caused kidney problems in some COVID-19 patients. ....

Tanishaa Nadkar , Shinjini Ganguli , Thomson Reuters Trust Principles , European Medicines Agency , Thomson Reuters Trust , Bio Therapeutic Drugs Trbc Level 5 , Company News , Corona Virus , Drug Amp Device Development , General Education Services Trbc Level 5 , Health Medicine , Medical Regulation , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Corporate Market Regulation , Reuters Top News , United States , ஷின்ஜினி கங்குலி , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை , நிறுவனம் செய்தி , கொரோனா வைரஸ் , மருந்து ஆம்ப் சாதனம் வளர்ச்சி , ஆரோக்கியம் மருந்து , மருத்துவ ஒழுங்குமுறை , பெருநிறுவன சந்தை ஒழுங்குமுறை ,

New Zealand to buy enough Pfizer COVID-19 vaccines for entire population

New Zealand will buy additional COVID-19 vaccines, developed by Pfizer Inc and Germany's BioNTech, which will be enough to vaccinate the whole country, Prime Minister Jacinda Ardern said on Monday. ....

New Zealand , United Kingdom , New South Wales , Michael Perry , Renju Jose , Jacinda Ardern , Thomson Reuters Trust Principles , Pfizer Inc , Prime Minister Jacinda Ardern , Thomson Reuters Trust , Corona Virus , Asia Pacific , Bio Therapeutic Drugs Trbc Level 5 , Company News , Drug Amp Device Development , General News , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Nec Trbc Level 5 , Government Politics , United States , புதியது ஜீலாந்து , ஒன்றுபட்டது கிஂக்டம் , புதியது தெற்கு வேல்ஸ் , மைக்கேல் பெர்ரி , ரென்ஜு ஜோசே , தாம்சன் ராய்ட்டர்ஸ் நம்பிக்கை ப்ரிந்ஸிபல்ஸ் ,

Science says it's safe, but some in France don't trust AstraZeneca vaccine

5 Min Read
PARIS (Reuters) - A 60-year-old recovering from breast cancer, Paris resident Nadine Roger is at high-risk from COVID-19 and wants to get vaccinated as soon as possible. Yet when she was offered the vaccine manufactured by AstraZeneca she turned it down.
“The AstraZeneca (shot) frightens me,” she said. Roger, a medical technician, said she would wait instead for the shot made by U.S. firm Johnson & Johnson, which has not yet been approved by European regulators.
According to the most recent data made available by the French health ministry, for the end of February, France was using 24% of its AstraZeneca doses, compared with 82% for vaccines made by Pfizer/BioNTech and 37% for the Moderna shot. ....

France General , United Kingdom , Lea Guedj , Olivier Nataf , Richard Lough , Christian Lowe , Nadine Roger , Alex Richardson , Jacques Battistoni , Caroline Pailliez , Thomson Reuters Trust Principles , President Emmanuel Macron , Astrazeneca France , Thomson Reuters Trust , Corona Virus , Drug Amp Device Development , Drug Safety , Healthcare Trbc Level 1 , Biotechnology Amp Medical Research Trbc Level 4 , Pharmaceuticals Amp Medical Research Trbc Level 2 , Public Health , Corporate Market Regulation , பிரான்ஸ் ஜநரல் , ஒன்றுபட்டது கிஂக்டம் , ரிச்சர்ட் லஃப் , கிறிஸ்துவர் குறைந்த ,

Philippines approves Sinovac vaccine but not for all health workers

By Reuters Staff
2 Min Read
MANILA (Reuters) - The Philippines has approved Sinovac Biotech’s COVID-19 vaccine for emergency use, but will not give it to healthcare workers at risk of exposure due to its varying levels of efficacy, its Food and Drugs Agency (FDA) said on Monday.
FILE PHOTO: A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter/File Photo
Late-stage trial data of Sinovac’s vaccine showed it had a lower efficacy when used for healthcare workers exposed to COVID-19 compared with healthy individuals age 18-59, said FDA chief Rolando Enrique Domingo. ....

Ed Davies , Rolando Enrique Domingo , Karen Lema , Neil Jerome Morales , Sinovac Coronavac , Harry Roque , Thomson Reuters Trust Principles , Drugs Agency , Sinovac Biotech , Rolando Enrique , Southeast Asian , Southeast Asia , Thomson Reuters Trust , Corona Virus , Asean Countries , Asia Pacific , Biopharmaceuticals Trbc Level 5 , Company News , China Prc , Diplomacy Foreign Policy , Drug Amp Device Development , Emerging Market Countries , General News , Health Medicine , Healthcare Trbc Level 1 , Infectious Diseases ,